COMMENT & RESPONSEIn Reply We thank Voinescu and colleagues for their comments on our recent article in JAMA Neurology. 1 We agree that there is no study to date to help in determining the optimal dose of folic acid supplementation for women with epilepsy. Our findings of an increased risk of cancer in children of mothers with epilepsy who are taking antiseizure medication and are exposed to high-dose folic acid indicate that there could be an upper dose limit above which the risks outweigh the benefits. This suggests an upper limit below the 4 to 5 mg per day recommended dosage to mothers with epilepsy by some major guidelines (eg, National Institute for Health and Care Excellence, Scottish Intercollegiate Guidelines Network).Unfortunately, for mothers with epilepsy, high-level evidence of the dose-related beneficial effects of folic acid supplementation on pregnancy outcomes is lacking. The classic randomized double-blind study demonstrating the efficacy of folic acid, 4 mg daily, in reducing the risk of neural tube defects in high-risk pregnancies excluded women with epilepsy. 2 Observational studies, such as the large-scale antiepileptic drugs and pregnancy registers, have failed to find an association between periconceptional folic acid supplementation and a reduced prevalence of major congenital malformations. 3,4 In contrast to studies of structural teratogenicity, other observational studies have reported improved developmental outcomes in the offspring of women with epilepsy associated with folic acid supplementation as referred to by Voinescu and colleagues in their letter, including full-scale IQ. 5 Although provision of folic acid supplementation to mothers with epilepsy who are taking antiseizure medications during pregnancy was clearly associated with important improvements in outcome, the appropriate dose remained unclear. The most frequently prescribed folic acid dose in the study by Meador and colleagues 5 was 4 mg or more daily, but only 6 of 225 children used doses of 0.4 mg or less. As stated by the authors, the group with the lowest dose (>0-0.4 mg daily) had an intermediate IQ between those of the group without folic acid and the group receiving greater than 0.4 mg daily, but it did not differ statistically from other groups.As stressed by Voinescu and colleagues, the results of our observational study indicating increased childhood cancer risk with high-dose folic acid supplementation needs to be replicated in independent studies. However, this discussion also highlights the need to determine what dose levels of folic acid are needed to obtain the beneficial effects. In the absence of this information, we suggest following guidelines for preg-nant women in general and to supplement at least 0.4 mg daily for women with epilepsy keeping folic acid doses less than or equal to 4 mg daily. Given the importance of the issue, it seems appropriate to consider performing randomized clinical studies comparing different dose levels of periconceptional folic acid supplementation to mothers receiv...